Minimally invasive surgery for remnant gastric cancer: a single-center retrospective study of treatment outcomes in Japan
MIS, including robotic gastrectomy, is feasible and safe for RGC, with potential perioperative benefits requiring multicenter validation.
Authors
- Junichi Mazaki (ORCID: https://orcid.org/0000-0002-0223-0921)
- Yoichiro Kaneko (ORCID: https://orcid.org/0009-0007-0606-2738)
- Hiroshi Kuwabara (ORCID: https://orcid.org/0000-0003-2953-587X)
- Edward F. Barroga (ORCID: https://orcid.org/0000-0002-8920-2607)
- Kenta Kasahara (ORCID: https://orcid.org/0000-0001-5997-5919)
- Junya Oguma
- T. Sakurai
- Masaya Enomoto (ORCID: https://orcid.org/0000-0002-1084-8780)
- Akishige Kanazawa (ORCID: https://orcid.org/0000-0001-8037-0818)
- Shohei Kondo
- Hiroyuki Koga (ORCID: https://orcid.org/0000-0002-5623-8689)
- Erika Yamada (ORCID: https://orcid.org/0009-0003-8682-5934)
- Yota Shimoda
- KENICHI IWASAKI (ORCID: https://orcid.org/0000-0002-1589-1526)
- Yuichi Nakagawa
- Hiroaki Osakabe
Institutions
- SHOWA Medical University (JP)
- Tokyo Medical University (JP)
Publication Details
- Journal
- Daehan nae'si'gyeong bog'gang'gyeong oe'gwa haghoeji/Journal of minimally invasive surgery
- Published
- 2026-03-15
- DOI
- https://doi.org/10.7602/jmis.2026.29.1.11
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00